In:
Tumori Journal, SAGE Publications, Vol. 74, No. 4 ( 1988-08), p. 393-395
Abstract:
The sensitivity of a new tumor marker, TA 4-SCC, for lung tumors is examined and compared with the performance of the already established CEA. TA 4-SCC sensitivity is only moderate (30 %), and it presents no significant differences among the various histologic types of lung cancer. In addition, unlike CEA, TA 4-SCC is present in large amounts in the serum of many stage I and II patients. In fact, its sensitivity in still curatively operable tumors reaches 30 % compared to 10 % with CEA.
Type of Medium:
Online Resource
ISSN:
0300-8916
,
2038-2529
DOI:
10.1177/030089168807400404
Language:
English
Publisher:
SAGE Publications
Publication Date:
1988
detail.hit.zdb_id:
280962-X
detail.hit.zdb_id:
2267832-3
Permalink